Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- Check4 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This update affects metadata rather than core content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history shows Revision: v3.6.5 replacing the previous v3.6.4, indicating a minor platform or UI update to the history page.SummaryDifference0.0%

- Check39 days agoChange DetectedThe record history now lists Revision: v3.6.4 as the latest entry and removes Revision: v3.6.3, reflecting a small maintenance update to the history log.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.6.3 was added to the history and Revision: v3.6.2 was removed, representing a small software version update to the page’s underlying system.SummaryDifference0.0%

- Check68 days agoChange DetectedA new revision entry (v3.6.2) was added to the page history, replacing the previous v3.6.0 entry. This indicates a minor update to the page's revision notes.SummaryDifference0.0%

- Check82 days agoChange DetectedThe study history now indicates enrollment is closed, and the record version has been updated to v3.6.0 (removing the prior v3.5.5).SummaryDifference0.3%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.